First Generic Version Of NuvaRing Gets FDA Nod, ONCT On Watch, SRPT Surges

Today's Daily Dose brings you news about the sweet surprise for Sarepta; spike in Amneal Pharma's stock price; Oncternal Therapeutics' breast cancer trial results and Centene's 2020 outlook.

from RTT - Biotech https://ift.tt/35hpqj9
via IFTTT